Calliditas Therapeutics (CALT) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Calliditas Therapeutics (CALT) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 2, 2023 (10:42)

Sector: Healthcare

The share price of Calliditas Therapeutics AB (publ) (CALT) now

What analysts predict: $40.67
52-week High/Low: $25.64 / $15.25

50/200 Day Moving Average: $17.37 / $19.05

This figure corresponds to the Average Price over the previous 50/200 days. For Calliditas Therapeutics stocks, the 50-day moving average is the support level today.

For Calliditas Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Calliditas Therapeutics AB (publ) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Calliditas Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Calliditas Therapeutics share be worth in 2023 - 2027?

When should I take profit in Calliditas Therapeutics stock? When should I record a loss on Calliditas Therapeutics stock? What are analysts' forecasts for Calliditas Therapeutics stock? What is the future of Calliditas Therapeutics stock? We forecast Calliditas Therapeutics stock performance using neural networks based on historical data on Calliditas Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Calliditas Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Calliditas Therapeutics shares. This happens once a day.




Historical and forecast chart of Calliditas Therapeutics stock

The chart below shows the historical price of Calliditas Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Calliditas Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, has focused on identifying, developing and commercializing pharmaceutical products for the treatment of orphan symptoms with an initial focus on kidney and liver diseases. The main candidate for the company’s products is Nefekon, an oral budesonide drug that is an immunosuppressive agent for the treatment of autoimmune IgA renal nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.

Calliditas Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 04 18.43 17.75 18.88 6.33
Dec 05 18.64 18.42 19.19 4.15
Dec 06 17.94 17.44 18.48 5.97
Dec 07 18.31 18.09 18.81 3.95
Dec 08 18.14 17.41 18.55 6.51
Dec 09 18.00 17.81 18.71 5.05
Dec 10 17.89 17.55 18.18 3.62
Dec 11 17.44 17.03 17.95 5.38
Dec 12 17.14 16.94 17.50 3.29
Dec 13 16.29 15.99 16.64 4.08
Dec 14 15.98 15.57 16.22 4.16
Dec 15 15.86 15.49 16.15 4.25
Dec 16 16.03 15.40 16.63 8.02
Dec 17 16.63 16.27 16.93 4.09
Dec 18 17.32 16.74 17.68 5.59
Dec 19 17.44 17.13 17.80 3.92
Dec 20 18.03 17.45 18.33 5.01
Dec 21 18.93 18.43 19.13 3.80
Dec 22 18.50 17.84 19.09 7.00
Dec 23 17.75 17.19 18.47 7.44
Dec 24 18.19 17.90 18.41 2.85
Dec 25 18.48 18.14 18.75 3.36
Dec 26 18.19 17.89 18.56 3.76
Dec 27 18.14 17.43 18.32 5.10
Dec 28 18.58 17.85 19.28 8.02
Dec 29 18.27 17.71 18.96 7.07
Dec 30 17.62 16.95 18.14 7.02
Dec 31 17.14 16.78 17.63 5.11
Jan 01 16.74 16.07 17.34 7.92
Jan 02 16.43 15.99 17.08 6.83

Calliditas Therapeutics Daily Price Targets


Calliditas Therapeutics Stock Forecast 12-04-2023.

Forecast target price for 12-04-2023: $18.43.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 5.957%.
Pessimistic target level: 17.75
Optimistic target level: 18.88

Calliditas Therapeutics Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $18.64.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.983%.
Pessimistic target level: 18.42
Optimistic target level: 19.19

Calliditas Therapeutics Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $17.94.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 5.631%.
Pessimistic target level: 17.44
Optimistic target level: 18.48

Calliditas Therapeutics Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $18.31.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.798%.
Pessimistic target level: 18.09
Optimistic target level: 18.81

Calliditas Therapeutics Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $18.14.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 6.112%.
Pessimistic target level: 17.41
Optimistic target level: 18.55

Calliditas Therapeutics Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $18.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 4.810%.
Pessimistic target level: 17.81
Optimistic target level: 18.71

CALT (CALT) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 20.41 18.67 21.96 15.01

Calliditas Therapeutics forecast for this year


Calliditas Therapeutics Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $20.4131. Pessimistic: $18.67. Optimistic: $21.96



Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 20.84 18.35 23.73 22.69
Mar 21.20 19.38 22.32 13.17
Mar 19.06 18.23 21.31 14.45
Apr 17.14 14.86 19.65 24.37
May 19.32 16.75 20.90 19.85
Jun 21.05 19.41 24.05 19.29
Jul 19.85 19.02 21.06 9.67
Aug 20.19 19.15 22.61 15.27
Sep 20.84 17.95 23.42 23.34
Oct 17.12 14.88 18.81 20.92
Nov 18.26 15.86 19.26 17.65
Dec 18.15 15.57 20.12 22.63

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 16.71 14.26 18.26 21.90
Mar 18.70 17.18 19.56 12.17
Mar 20.02 18.12 20.86 13.13
Apr 23.52 21.87 26.33 16.97
May 26.56 22.98 29.84 23.00
Jun 27.31 23.94 29.65 19.25
Jul 26.48 23.72 28.60 17.07
Aug 25.28 23.55 27.77 15.22
Sep 23.16 20.21 25.36 20.30
Oct 24.26 23.11 25.69 10.05
Nov 23.66 22.09 25.78 14.30
Dec 22.50 21.43 25.23 15.08

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 24.33 22.67 27.34 17.08
Mar 28.36 25.66 30.46 15.74
Mar 25.02 21.97 26.20 16.14
Apr 20.55 17.42 22.07 21.05
May 18.40 16.58 20.22 17.98
Jun 17.00 16.32 18.00 9.33
Jul 17.55 15.38 19.99 23.03
Aug 18.02 16.85 19.35 12.91
Sep 20.31 17.42 22.82 23.68
Oct 21.39 20.25 24.56 17.54
Nov 23.47 22.53 24.62 8.51
Dec 24.18 20.73 25.74 19.45

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 28.22 24.57 30.10 18.35
Mar 30.96 29.60 34.07 13.12
Mar 27.90 26.52 31.08 14.67
Apr 28.32 26.60 31.87 16.55
May 28.27 25.47 29.88 14.74
Jun 26.71 24.58 29.60 16.97
Jul 29.75 26.08 33.03 21.05
Aug 28.29 24.31 32.32 24.78
Sep 29.84 26.55 32.96 19.44
Oct 29.79 25.60 33.86 24.40
Nov 33.24 31.79 36.90 13.86
Dec 34.31 31.97 36.33 12.02

Calliditas Therapeutics information and performance

Calliditas Therapeutics Address

KUNGSBRON 1, C8, STOCKHOLM, SE

Market Capitalization: 503 980 000 $

Market capitalization of the Calliditas Therapeutics AB (publ) is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CALT shares in the company outstanding by the market price of one share.

EBITDA: -356 124 736 $

EBITDA of Calliditas Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.61

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.133
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 12.74

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.415

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.459

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 26836000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.